beta-alanine has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amartey, JK | 1 |
| Shi, Y | 1 |
| Al-Jammaz, I | 1 |
| Esguerra, C | 1 |
| Al-Otaibi, B | 1 |
| Al-Mohanna, F | 1 |
1 other study available for beta-alanine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Radioiodinated naphthylalanine derivatives targeting pancreatic beta cells in normal and nonobese diabetic mice.
Topics: Animals; Autoradiography; beta-Alanine; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Dia | 2008 |